Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 50 51 52 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Inotrem S.A.. (3/13/14). "Press Release: Inotrem Raises EUR18 Million to Develop Innovative Sepsis Treatments in a Series A Financing Co-led by Edmond de Rothschild Investment Patners and Sofinnova Partners". Paris & Nancy. 2014-03-13
Bayer AG. (3/13/14). "Press Release: Pulmonary Arterial Hypertension (PAH). Start of Phase IIIb Study with Bayer’s Riociguat in PAH Patients who Demonstrate an Insufficient Response to PDE-5 Inhibitors [Not intended for U.S. and UK Media]". Berlin. 2014-03-13
Actelion Ltd.. (3/13/14). "Press Release: Actelion Provides Update on Asahi Litigation". Allschwil. 2014-03-13
Sysmex Corporation. (3/13/14). "Press Release: Sysmex Enters into Clinical Research, Joint Development and Licensing Agreement with Merck Millipore". 2014-03-13
Vectura Group plc. (3/13/14). "Press Release: Acquisition of Activaero". Chippenham. 2014-03-13
DISCO project. (3/13/14). "Press Release: Planning for the Future. Successful DISCO Kick-Off at Cumberland Lodge, UK". 2014-03-13
Bicoll GmbH. (3/12/14). "Press Release: 40,000 Historic Formulations as Starting Point for New Drugs. Research Project EPICLEAP Receives Partial Funding from the German Federal Ministry of Education and Research". Munich & Berlin. 2014-03-12
Formycon AG. (3/12/14). "Press Release: Licensing Out of the First Biosimilar Development Project Already Enables Extension of the Product Pipeline as of 2014". Munich. 2014-03-12
Paion AG. (3/12/14). "Press Release: Paion AG Reports Financial Results for the Full Year 2013". Aachen. 2014-03-12
Ecron Acunova GmbH. (3/12/14). "Press Release: Anders Malm Appointed Managing Director at Ecron Acunova GmbH". Marlborough. 2014-03-12
Qiagen N.V.. (3/12/14). "Press Release: Qiagen N.V. Announces Successful Completion of Non-U.S. Offer Involving Convertible Notes". Hilden. 2014-03-12
Chemie.DE Information Service GmbH. (3/11/14). "Press Release: All the Important Trade Fairs, Congresses, Seminars and Webinars at a Glance". Berlin. 2014-03-11
Glycotope GmbH. (3/11/14). "Press Release: Glycotope Secures One of the Largest Financing Rounds in the European Biotech Sector". Berlin. 2014-03-11
Bayer AG. (3/11/14). "Press Release: Phase III Trial of Sorafenib as Adjuvant Therapy for Liver Cancer Did Not Meet Primary Endpoint [Not intended for U.S. and UK Media]". Berlin. 2014-03-11
Bayer AG. (3/11/14). "Press Release: Bayer to Invest More than 500 Million Euros for the Manufacturing of Hemophilia A Products Currently in Development [Not intended for U.S. and UK Media]". Leverkusen. 2014-03-11
Galenica. (3/11/14). "Press Release: Results of the Galenica Group for 2013". Bern. 2014-03-11
Exosome Diagnostics, Inc.. (3/11/14). "Press Release: Exosome Diagnostics Raises $27 Million in Series B Financing". New York City. 2014-03-11
Tecan Group Ltd.. (3/11/14). "Press Release: Full Year 2013. Tecan Records Higher Profit and Important Progress in the Implementation of Its Strategy". Männedorf. 2014-03-11
CureVac GmbH. (3/10/14). "Press Release: CureVac Wins Two Million EUR from Inaugural European Commission Vaccine Prize. RNActive Vaccines Offer Excellent Conditions for Cost-effective Worldwide Distribution". Tübingen & Brussels. 2014-03-10
Kythera Biopharmaceuticals, Inc.. (3/10/14). "Press Release: Kythera Acquires Rights to ATX-101 Outside of the US and Canada from Bayer Consumer Care". Calabasas, CA. 2014-03-10
Sony DADC. (3/10/14). "Press Release: Sony DADC and Opko Diagnostics Announce Manufacturing Partnership". Salzburg & Miami, FL. 2014-03-10
Eppendorf AG. (3/10/14). "Press Release: Eppendorf’s New Mastercycler Nexus X2 Provides Multi-block Solution for High Volume, Simultaneous PCR Runs". Hamburg. 2014-03-10
Symrise AG. (3/10/14). "Press Release: Symrise Achieves Record Levels in Sales and Profitability in 2013". 2014-03-10
EMD Millipore. (3/10/14). "Press Release: EMD Millipore Receives Grant from Massachusetts Life Sciences Center to Collaborate with Promethera Biosciences". Billerica, MA. 2014-03-10
Biognosys AG. (3/7/14). "Press Release: Biognosys and FGCZ Announce Collaboration on SpectroDive PRM Testing". Zürich-Schlieren. 2014-03-07
Merck KGaA. (3/6/14). "Press Release: Merck Reports Record Result for 2013". Darmstadt. 2014-03-06
Boehringer Ingelheim. (3/6/14). "Press Release: Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-infected Patients Treated Faldaprevir [For media outside of the US, the UK & Canada only]". Ingelheim & Ridgefield, CT. 2014-03-06
Boehringer Ingelheim. (3/6/14). "Press Release: Pradaxa (dabigatran etexilate) Now Approved in more than 100 Countries for Stroke Prevention in Atrial Fibrillation [For media outside of the US, the UK & Canada only]". Ingelheim & Ridgefield, CT. 2014-03-06
Debiopharm S.A.. (3/6/14). "Press Release: Debiopharm Group to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)". Lausanne. 2014-03-06
Merck KGaA. (3/6/14). "Press Release: Merck’s Consumer Health Division Breaks $1bn Barrier through Transition of Neurobion and Floratil Brands from Merck Serono". Darmstadt. 2014-03-06
Debiopharm S.A.. (3/5/14). "Press Release: Immunexpress Closes USD 6 Million Financing Round Led by Debiopharm Group". Lausanne & Seattle, WA. 2014-03-05
Evolva Holding S.A.. (3/5/14). "Press Release: Exercise of Over-allotment Option in Evolva’s Share Placement [Not for Distribution in or into the United States, Canada, Australia or Japan]". Reinach. 2014-03-05
MeVis Medical Solutions AG. (3/5/14). "Press Release: Preliminary Figures 2013". Bremen. 2014-03-05
Agenus Inc.. (3/5/14). "Press Release: Agenus Reports Fourth Quarter and Full Year 2013 Financial Results". Lexington, MA. 2014-03-05
KCR S.A.. (3/4/14). "Press Release: KCR Strenghtens Its Footprint in Western Europe. Dynamic European CRO Registers New Entities in the UK and Germany". Warsaw. 2014-03-04
Curetis AG. (3/4/14). "Press Release: Curetis Prepares Launch of Second Unyvero Application". Holzgerlingen. 2014-03-04
EKF Diagnostics Holdings plc. (3/4/14). "Press Release: Transfer of Production". 2014-03-04
Evolva Holding S.A.. (3/4/14). "Press Release: Evolva Reaches Second Milestone Roquette Collaboration". Reinach. 2014-03-04
ProBioGen AG. (3/4/14). "Press Release: ProBioGen and Merus Sign Deal on GlymaxX ADCC Enhancement Technology". Berlin & Utrecht. 2014-03-04
Roche. (3/4/14). "Press Release: Roche Annual General Meeting 2014. Christoph Franz Elected as Chairman of the Board of Directors – 27th Consecutive Dividend Increase". Basel. 2014-03-04
4SC AG. (3/4/14). "Press Release: 4SC AG Issues First Tranche of Convertible Notes with a Nominal amount of EUR 500,000 to Yorkville". Planegg-Martinsried. 2014-03-04
Thermo Fisher Scientific Inc.. (3/3/14). "Press Release: Thermo Fisher Scientific Strenghtens Innovation Leadership with New Products Launched at Pittcon 2014". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Launches Next-generation GC-APCI II GC-MS Interface with Automatic MS Calibration for Metabolomics and Small Molecule Research". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Launches New autoflex speed MALDI-TOF(/TOF) with 2 kHz Smartbeam Laser". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Announces Next Generation JuiceScreener 3.0". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: MIR-FIR Spectroscopy in One Step – an FT-IR Dream Becomes a Reality". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: At Pittcon 2014, Bruker Introduces Numerous New and Enhanced Customer-driven Products for Life-Science Research, Industrial and Applied Markets". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker’s New TopSolids Software Provides Accelerated Workflow in Solid-state NMR for the Characterization of Protein Structures". Chicago, IL. 2014-03-03
MorphoSys AG. (3/3/14). "Press Release: MorphoSys to Start Share Buy-back Program". 2014-03-03
Roche. (3/3/14). "Press Release: Roche Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer". Basel. 2014-03-03
Sartorius AG. (3/3/14). "Press Release: Sartorius Reviews Fiscal 2013 Results". Göttingen. 2014-03-03
Boehringer Ingelheim. (3/1/14). "Press Release: AAAAI 2014. Asthma – New Phase III Data Show Tiotropium Respimat Effective Across Asthma Severities [For Media outside the U.S., Canada and UK]". San Diego, CA. 2014-03-01
Poly-Pico Technologies Ltd.. (3/14). "Press Release: New Open Access Platform Desktop Spotter to Be Unveiled at Analytica in Germany". 2014-03-01
Biognosys AG. (2/28/14). "Press Release: Biognosys Introduces New Multiplexed MRM Assay Panel for Depleted Plasma – PlasmaDeepDive". Zürich-Schlieren. 2014-02-28
Roche. (2/28/14). "Press Release: Roche and Discuva Join Forces to Combat Life-threatening Infections Caused by Multi-drug Resistant Bacteria". Basel & Cambridge. 2014-02-28
MorphoSys AG. (2/28/14). "Press Release: MorphoSys AG Reports Results for Fiscal Year 2013. Financial Results at the Upper End of 2013 Guidance". 2014-02-28
Spark Holland B.V.. (2/28/14). "Press Release: Spark Holland Innovative Technology Used in Gerstel Integrated Solutions. Spark Holland OEM Agreement Including Patented DBS Technology". 2014-02-28
microDimensions GmbH. (2/27/14). "Press Release: microDimensions GmbH Successfully Closes Seed Round". Munich. 2014-02-27
InSphero AG. (2/27/14). "Press Release: InSphero Granted Hanging Drop Patents in China and Japan". Schlieren. 2014-02-27
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
Epigenomics AG. (2/26/14). "Press Release: Epigenomics AG Reports Preliminary Results and Highlights for the Year Ended December 31, 2013". Berlin & Germantown, MD. 2014-02-26
Algeta ASA. (2/26/14). "Press Release: Bayer’s Voluntary Cash Offer to Acquire the Entire Issued Share Capital of Algeta Is Successful". Oslo. 2014-02-26
Evolva Holding S.A.. (2/26/14). "Press Release: Evolva Successfully Places New Shares". 2014-02-26
BRAIN AG. (2/25/14). "Press Release: BRAIN Takes Over Anti-bitter Patents and Utility Patent Portfolio from BASF". Zwingenberg. 2014-02-25
Wilex AG. (2/24/14). "Press Release: Professor Olaf G. Wilhelm Leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand Will Lead the Company". Munich. 2014-02-24
Roche. (2/21/14). "Press Release: Roche Signs Licensing Agreement with Sysmex Inostics GmbH for emPCR Patent Portfolio". Pleasanton, CA. 2014-02-21
Roche. (2/21/14). "Press Release: Roche Launches New Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening. New Automated CINtec Plus Test Improves the Detection of Cervical Pre-cancer". Basel. 2014-02-21
Givaudan S.A.. (2/21/14). "Press Release: Givaudan Strengthens Process Development and Research Capabilities. Enters into Exclusive Negotations with ARD to Acquire Soliance". Geneva. 2014-02-21
BB Biotech AG. (2/20/14). "Press Release: Publication of 2013 Annual Report of BB Biotech AG". 2014-02-20
High-Tech Gründerfonds Management GmbH. (2/20/14). "Press Release: Amal Therapeutics SA Raises Seed Round from Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds to Develop Therapeutic Cancer Vaccines Based on Its Proprietary Technology Platfor 2014-02-20
Merck KGaA. (2/20/14). "Press Release: Merck Appoints Simon Sturge as New Head of Biosimilars Unit". Darmstadt. 2014-02-20
Proteros Biostructures GmbH. (2/20/14). "Press Release: Proteros Announces Election of Prof. Eric-Paul Pâques, CEO of Grünenthal, as New Supervisory Board Member". Munich. 2014-02-20
LifeLabs Medical Laboratory Services. (2/19/14). "Press Release: LifeLabs Medical Laboratory Services Acquires Centogene’s Canadian Business". Toronto, ON. 2014-02-19
Bruker Corporation. (2/18/14). "Press Release: Bruker Reports Fourth Quarter and Full Year 2013 Financial Results". Billerica, MA. 2014-02-18
Ionicon Analytik GmbH. (2/18/14). "Press Release: Ionicon Launches the New Super-fast PTR-TOF 1000 Trace Gas Analyzer". Innsbruck. 2014-02-18
Novimmune S.A.. (2/18/14). "Press Release: Novimmune Announces Closing of CHF 60 Million Financing". Geneva. 2014-02-18
BioOutsource Ltd.. (2/18/14). "Press Release: BioOutsource Expands ADC Characterisation Capabilities. A Global Leader in ADC Characterisation, BioOutsource, Partners with Glythera". Glasgow. 2014-02-18
Markes International Ltd.. (2/18/14). "Press Release: New Ground-breaking Ion Source Technology for GC-MS Launched at Pittcon 2014". 2014-02-18
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (2/17/14). "Pressemitteilung: W3-Professuren für MDC- und Charité-Forscher". 2014-02-17
Stratec Biomedical AG. (2/17/14). "Press Release: Dr. Claus Vielsack Appointed Member of the Management Board of Stratec for Product Development". Birkenfeld. 2014-02-17
HBM Healthcare Investments Ltd.. (2/17/14). "Press Release: HBM Healthcare Investments Participates with EUR 20 Million in Financing Round of Advanced Accelerator Applications [Not for distribution in the USA, Canada, Japan or Australia]". Zug. 2014-02-17
Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes €41 Million Fund Raising". Saint-Genis-Pouilly. 2014-02-17
Horizon Discovery Ltd.. (2/17/14). "Press Release: Horizon Discovery Signs Supply and Distribution Agreement with Sirion Biotech GmbH". Cambridge. 2014-02-17
Boehringer Ingelheim. (2/17/14). "Press Release: Boehringer Ingelheim Receives East Bay Innovation Award". Fremont, CA. 2014-02-17
Boehringer Ingelheim GmbH. (2/17/14). "Pressemitteilung: IQWiG bescheinigt Zusatznutzen für Giotrif (afatinib)". Ingelheim. 2014-02-17
MorphoSys AG. (2/17/14). "Press Release: MorphoSys Announces Clinical Milestone in Anti-inflammatory Program". 2014-02-17
Novartis AG. (2/17/14). "Press Release: Novartis Expands Cancer Immunotherapy Research Program with Acquisition of CoStim". Basel. 2014-02-17
Universitätsmedizin Mainz. (2/14/14). "Pressemitteilung: Grundsteinlegung für Paul-Klein-Zentrum für Immunintervention. Universitätsmedizin Mainz bekommt einen hochmodernen Forschungsneubau". 2014-02-14
Enzymatics, Inc.. (2/14/14). "Press Release: Enzymatics Launches Archer NGS. Identifies Known and Novel Gene Fusions without Prior Knowledge of Breakpoints or Fusion Partners". Marco Island, FL. 2014-02-14
Analytik Jena AG. (2/13/14). "Press Release: Analytik Jena AG with Double-digit Sales and Earnings Growth after Three Months". Jena. 2014-02-13
Carl Zeiss Meditec AG. (2/13/14). "Press Release: Carl Zeiss Meditec AG – Cautious Start to the New Financial Year, after Strong Annual Results. Negative Currency Effects Hinder Growth in the First Quarter". Jena. 2014-02-13
Nestlé S.A.. (2/13/14). "Press Release: Full-year 2013 – 4.6% Organic Growth, Trading Operating Profit Magin up 20 Basis Points, up 40 Basis Points in Constant Currencies". Vevey. 2014-02-13
Mannheim. (2/13/14). "Pressemitteilung: Operation Zukunft – Sympbolischer Spatenstich für Medizintechnologie-Zentrum". 2014-02-13
Cytos Biotechnology AG. (2/13/14). "Press Release: Cytos Biotechnology Announces Full Year 2013 Financial Results". Schlieren. 2014-02-13
Agenus Inc.. (2/13/14). "Press Release: Agenus Closes Acquisition of 4-Antibody". Lexington, MA. 2014-02-13
Redx Pharma Ltd.. (2/12/14). "Press Release: €85 Million European Programme Targets Novel Antibiotics. Redx Pharma Joins Global Consortium to Tackle Growing Threat from Antibiotic Resistance". 2014-02-12
4SC AG. (2/12/14). "Press Release: Continued Funding of 4SC AG. Investor Undertakes to Subscribe to Convertible Notes for up to EUR 15 Million Nominally [Ad hoc Announcement] ". Planegg-Martinsried. 2014-02-12
Ganymed Pharmaceuticals AG. (2/12/14). "Press Release: Ganymed’s IMAB027 Enters Phase I/II Clinical Trial for Ovarian Cancer". Mainz. 2014-02-12
High-Tech Gründerfonds Management GmbH. (2/12/14). "Press Release: Coramaze Technologies GmbH Receives € 1 Million to Develop an Innovative Medical Device for the Minimally Invasive Treatment of Heart Valve Diseases". Essen, Dortmund & Bonn. 2014-02-12
Paion AG. (2/12/14). "Press Release: Paion Completes Private Placement through the Issuance of New Shares in a Placement Volume of EUR 3.17 Million [Not for distribution or release, directly or indirectly, in or into the United States or any other jurisd 2014-02-12
next pagenext page 1 2 3 ... 50 51 52 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top